Therefore, MAPK signaling pathways were involved in PSH mediated MMP-2 regulation in NPC and blocking the ERK or JNK pathway might interfere the anti-metastatic ability of PSH to NPC cells. The gene discussed is MMP2; the disease is nasopharyngeal carcinoma.